Email Updates

You are here

Home

14 DECEMBER 2018 VOLUME 19 ISSUE 50

Media Coverage

  • NIH to Fund HIV Care and Prevention Research in the South

    A new NIH program focusing on HIV research will take aim at a particularly vulnerable area of the United States: the South. The research will evaluate strategies to help those living with or at risk for HIV with medical care and preventive services. These include the use of proven HIV treatment and prevention tools, including ART, pre-exposure prophylaxis and post-exposure prophylaxis.

    December 14, 2018
    Combination Prevention, General
    Healio

  • Two cochairs named for Presidential Advisory Council on HIV/AIDS

    At the end of 2017, the number of members on the Presidential Advisory Council on HIV/AIDS (PACHA) was zero. That’s because earlier in the year, six resigned in protest of Trump’s policies. By the end of December 2017, the president had terminated the remaining 16 members via a letter delivered by FedEx. Throughout all of this year, PACHA had no members. Until now.

    December 13, 2018
    General
    POZ

  • UN HIV/AIDS agency assailed for culture of harassment

    An independent panel that evaluated sexual harassment, bullying, and abuses of power at the Joint United Nations Programme on HIV/AIDS (UNAIDS) issued a blistering report that called for a change in leadership to address what it called a "vacuum of accountability."

    December 13, 2018
    Science Magazine

  • Fears of AIDS epidemic in Venezuela as HIV patients rely on futile leaf remedy amid drug shortage

    As Venezuela's hyperinflation and chronic medicine shortages leave HIV patients with little hope of obtaining antiretroviral drugs, many are now relying on the leaves of a tropical tree known as the guasimo.

    December 13, 2018
    Treatment
    Daily Mail

  • Older tenofovir may not be tied to fracture risk after all

    A new analysis from French researchers calls into question whether Gilead Sciences’ mainstay antiretroviral (ARV) tenofovir disoproxil fumarate (TDF) is associated with bone fracture, as has long been presumed, aidsmap reports.

    December 13, 2018
    Treatment
    POZ

  • Sweden freezes support to UNAIDS until leader removed

    Sweden said Wednesday it was freezing its support to UNAIDS until its executive director is removed, after an expert report blasted the agency's leadership for systematically failing to address bullying, abuse and sexual harassment.

    December 12, 2018
    General
    France 24

  • Researchers Identify Compounds that “Block & Lock” HIV

    Scientists have identified compounds that inhibit the reactivation of cells that are latently infected with HIV, meaning they are not replicating and producing new copies of the virus.

    December 12, 2018
    Cure, Treatment
    POZ

  • Why I declared my HIV status in parliament – and what needs to happen next

    Last month, I became the first MP to disclose in the House of Commons that they were HIV positive.

    December 12, 2018
    General
    Independent

  • Innovative self-screening STI, HIV clinic opens in Montreal

    An innovative self-screening service to test for sexually transmitted infections has just opened at a downtown Montreal's Quorum Medical Clinic.

    December 12, 2018
    General
    CTV Montreal

  • Trump Signed a Good Law This Week. Yes, Really

    On Tuesday, something odd happened in Washington: A bill became a law. It passed by unanimous consent in the Senate and voice vote in the House (typically taken when a measure faces no significant opposition), and was signed by President Donald Trump.This wasn’t a trivial, “let’s rename a post office” bill either. The bill reauthorized PEPFAR — the President’s Emergency Plan for AIDS Relief — through 2023. PEPFAR provides billions in annual funding and technical support for antiretroviral treatment, HIV-preventing male circumcisions, and other efforts to treat and prevent HIV.

    December 12, 2018
    Combination Prevention, General, PrEP, Treatment, Voluntary Medical Male Circumcision
    Vox

  • Stigma, access and testing: why HIV is still rising in Europe

    The latest annual surveillance report by the European Centre for Disease Prevention and Control (ECDC) shows that Europe maintains its distinction as the World Health Organization region with the largest increase in HIV cases in a year, and one of only two of the six global regions (the other being the Middle East and north Africa) that has not seen cases decline. Two-thirds of all cases were in a single country: Russia, which had 65.5 percent of new diagnoses in the European region, even though it only has 16 percent of its population.

    December 11, 2018
    General
    aidsmap

  • A makeover for oral PrEP: designing real-world HIV prevention for women

    Time and time again, women have told me they are waiting for a solution that would put them in control of protecting themselves against HIV. While there are microbicides on the horizon, like a vaginal ring and other delivery methods, the best and only prevention option right now is oral pre-exposure prophylaxis (PrEP), a formulation of the same medicines used for treating people who are HIV-positive.

    December 11, 2018
    PrEP
    STAT

  • Can PrEP on demand for HIV prevention work in the US? Experts answer your questions

    The evidence is already three years old: As posted published on in TheBodyPRO.com in February 2016, researchers published reported the results of a study among 400 gay men in France and Canada showing efficacy of an "on-demand" approach for short-term pre-exposure prophylaxis (PrEP).

    December 11, 2018
    PrEP
    The BodyPro

  • Complacency kills: Prevention cannot take a backseat while we scale up treatment coverage to #endAIDS

    Unprecedented progress has happened in fight against AIDS globally, but formidable challenges remain. Are we making enough progress on HIV prevention, treatment and care, in communities and places where HIV incidence is likely to be higher?

    December 11, 2018
    General
    Social Post

  • AIDSfree appeal: ‘There’s an HIV drug with 99% success rate… now let’s make it available to all’

    Campaigners have called on the NHS to make a breakthrough preventive HIV treatment available immediately or risk a rise in numbers of those contracting the virus.

    December 11, 2018
    PrEP
    Evening Standard

  • With 1,000 infections a day, the fight against HIV/AIDS is far from over

    The Treatment Action Campaign (TAC), which played a key role in getting the government to provide anti-retroviral drugs to prevent mother-to-child transmission of HIV, says there is still a long way to go in the fight against the virus.

    December 10, 2018
    General
    Times

  • Alternative to AIDS 2020 Conference to be held in Mexico City

    A group of HIV activists are organizing an alternative HIV conference in Mexico City to be held concurrently with the July 2020 International AIDS Conference 2020 (AIDS 2020) in San Francisco, according to a press release from the activists. AIDS 2020 will take place July 6 through 10, while the parallel HIV2020 will run from July 6 through 8.

    December 10, 2018
    General
    POZ

  • AIDSfree: Kenya’s Condom King and His Mission to Combat HIV Taboos

    When Stanley Ngara started teaching young Kenyans about safe sex he found many of those present too embarrassed to listen to his message on how they could avoid catching HIV.

    December 10, 2018
    Male and Female Condoms
    Independent

  • CDC: HIV rates in Atlanta now officially an epidemic

    Health officials from the Centers for Disease Control and Prevention announced on Thursday that Atlanta remains in an HIV/AIDS health crisis and ranks fourth in the nation for new HIV diagnoses, WSBTV reports.

    December 10, 2018
    General
    HIV Plus Mag

  • Trump administration halts study that would use fetal tissue ‘to discover a cure for HIV’

    The Trump administration has shut down at least one government-run study that uses fetal tissue implanted into mice even before federal health officials reach a decision on whether to continue such research, which is opposed by antiabortion groups.

    December 9, 2018
    Cure
    Washington Post

Published Research

Announcements